Project Grant R21NS137252
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$433K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This federal Project Grant award of $649,226 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) grant program, supports research to investigate mechanisms of therapeutic resistance and mesenchymal transition in glioblastoma (GBM) brain tumors. The research aims to dissect and target the acetylated RelA (NF-κB subunit):BET protein complex, which acts as a regulatory switch...
This $678,879 Project Grant awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports research by Cold Spring Harbor Laboratory (CSHL) to investigate a novel epigenetic vulnerability in glioblastoma (GBM), the most common and deadly adult primary brain cancer. The key focus is elucidating the mechanism by which targeting the chromatin regulator BRD8 can re-establish p53-mediated tumor suppression in GBM lacking p53 mutations,...
This $578,632 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program supports research to investigate the epigenetic mechanisms underlying neuronal activity-induced gene expression and synaptic plasticity. The research will focus on determining how neuronal activity-induced phosphorylation of the chromatin remodeling protein BRG1...
This $460,940 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to investigate the impact of glioma-associated germline risk alleles on neurodevelopmental trajectories. The research focuses on elucidating the epigenetic and transcriptional mechanisms by which two specific glioma-associated risk SNPs, rs7572263 and rs78378222, dysregulate...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $448,250 to The Research Foundation For The State University Of New York (Upstate Medical Center) to support research focused on disrupting radioresistance in glioblastoma, an aggressive brain cancer, by targeting scaffolding proteins. The project aims to characterize how genetic...
This $687,279 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support research to dissect the immune responses and cellular composition within the tumor microenvironment of glioblastoma (GBM). The project aims to leverage spatial transcriptomics and proteomics analysis of archival human GBM samples and mouse models to uncover the effects...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $574,427 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the University of Pittsburgh to investigate the role of amino acid metabolism in regulating the growth and immune interactions of glioblastoma, an aggressive form of brain cancer. The research aims to uncover the molecular and cellular mechanisms by which selective amino acid catabolism in glioblastoma...
This federal Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to define the circuit connectivity between glioblastoma brain tumors and diverse neuronal populations in a mouse model. The $195,896 award to The Trustees of the University of Pennsylvania will enable the utilization of monosynaptic viral tracing techniques to...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $449,203 to support research aimed at investigating the interaction between glioblastoma (GBM), the most aggressive form of brain cancer, and the subventricular zone (SVZ) neurogenic niche in the lateral ventricles. The research, led by Mayo Clinic Jacksonville, a nonprofit...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $676,789.00 to the Buck Institute for Research on Aging to investigate the role of mRNA methylation in regulating synaptic activity and neurotransmitter release. The research aims to (1) establish critical roles for the epitranscriptome in normal synaptic function,...